© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Annovis Bio, Inc. (ANVS) stock surged +0.13%, trading at $7.87 on NYSE, up from the previous close of $7.86. The stock opened at $7.77, fluctuating between $7.45 and $7.92 in the recent session.
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.
Employees | 6 |
Beta | 1.728 |
Sales or Revenue | $0.00 |
5Y Sales Change% | 0% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
Annovis Bio, Inc. (NYSE: ANVS) stock price is $7.87 in the last trading session. During the trading session, ANVS stock reached the peak price of $7.92 while $7.45 was the lowest point it dropped to. The percentage change in ANVS stock occurred in the recent session was 0.13% while the dollar amount for the price change in ANVS stock was $0.01.
The NYSE listed ANVS is part of Biotechnology industry that operates in the broader Healthcare sector. Annovis Bio, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Eve M. Damiano M.S., RAC
Senior Vice President of Regulatory Operations
Dr. Maria L. Maccecchini Ph.D.
Founder, Chief Executive Officer, Pres & Executive Director
Mr. Henry Hagopian III, M.B.A.
Chief Financial Officer
Dr. Cheng Fang Ph.D.
Senior Vice President of R&D
ANVS's closing price is 73.73% higher than its 52-week low of $4.53 where as its distance from 52-week high of $22.49 is -65.01%.
Number of ANVS employees currently stands at 6.
Official Website of ANVS is: https://www.annovisbio.com
ANVS could be contacted at phone 610 727 3913 and can also be accessed through its website. ANVS operates from 1055 Westlakes Drive, Berwyn, PA 19312, United States.
ANVS stock volume for the day was 128.65K shares. The average number of ANVS shares traded daily for last 3 months was 1.77M.
The market value of ANVS currently stands at $102.73M with its latest stock price at $7.87 and 13.05M of its shares outstanding.